Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ludwig

Showing results (291-300 of 500) with videos related to

Pageof 50
Sort By:
Molecular Pharmaceutics|May 27, 2020
Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like SpecificityYulei Zhang, Lina Wu, Priyanka Gupta, et al.
Klinische Wochenschrift|August 1, 1988
Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typingA Krämer, D Herth, H J von Keyserlingk, et al.
Leukemia|January 1, 1992
The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study GroupD Hoelzer, E Thiel, W D Ludwig, et al.
Leukemia|February 1, 1995
Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemiaG Meckenstock, A Heyll, E M Schneider, et al.
The Journal of Experimental Medicine|April 1, 1993
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genesT M Breit, E J Mol, I L Wolvers-Tettero, et al.
Leukemia|April 1, 1989
Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked lociC R Bartram, W D Ludwig, W Hiddemann, et al.
Leukemia|November 21, 2008
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after inductionR Ratei, G Basso, M Dworzak, et al.
Deutsche Medizinische Wochenschrift (1946)|May 13, 1988
[Pulmonary complications in acquired immunodeficiency syndrome. Results of a prospective study]G Höffken, H Lode, T Dissmann, et al.
Klinische Padiatrie|July 1, 1994
[Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow]M Schrappe, A Reiter, S Sauter, et al.
Leukemia & Lymphoma|January 1, 1993
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Pageof 50

Showing results (291-300 of 500) with videos related to

Sort By:
Pageof 50
Molecular Pharmaceutics|May 27, 2020
Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like SpecificityYulei Zhang, Lina Wu, Priyanka Gupta, et al.
Klinische Wochenschrift|August 1, 1988
Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typingA Krämer, D Herth, H J von Keyserlingk, et al.
Leukemia|January 1, 1992
The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study GroupD Hoelzer, E Thiel, W D Ludwig, et al.
Leukemia|February 1, 1995
Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemiaG Meckenstock, A Heyll, E M Schneider, et al.
The Journal of Experimental Medicine|April 1, 1993
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genesT M Breit, E J Mol, I L Wolvers-Tettero, et al.
Leukemia|April 1, 1989
Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked lociC R Bartram, W D Ludwig, W Hiddemann, et al.
Leukemia|November 21, 2008
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after inductionR Ratei, G Basso, M Dworzak, et al.
Deutsche Medizinische Wochenschrift (1946)|May 13, 1988
[Pulmonary complications in acquired immunodeficiency syndrome. Results of a prospective study]G Höffken, H Lode, T Dissmann, et al.
Klinische Padiatrie|July 1, 1994
[Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow]M Schrappe, A Reiter, S Sauter, et al.
Leukemia & Lymphoma|January 1, 1993
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparisonW Hiddemann, C Aul, G Maschmeyer, et al.
Pageof 50